COVID-19 Vaccination

COVID-19 Vaccination Rollout Webinars

Archive of all COVID-19 vaccination webinar recordings and resources.

Current Resources

Printed collateral (e.g., posters), training and educational materials, social media, videos and Government guidance. Updated regularly.

See all resources

Frequently Asked Questions

What training is required of community pharmacies to vaccinate?

Pharmacists must have completed an approved pharmacist vaccination course in addition to mandatory COVID-19 vaccination training.

The Australian College of Nursing has been appointed by the Australian Government to lead the development of the mandatory training materials for COVID-19 immunisation providers. Healthcare professionals will not be able to administer any COVID-19 vaccines without having first completed the training modules.

Training for immunisation providers includes:

  • handling and storage
  • multi-dose vial (MDV) training
  • delivery mechanisms of the vaccine
  • administrative reporting including eligibility checking
  • safety and surveillance monitoring and reporting for adverse events following immunisation
  • communication.

Enrolling in the training

To enrol in the course, immunisation providers will be required to have already undertaken routine immunisation training specific to their profession and hold a current practising registration  Immunisation providers will be required to enrol through their Australian Health Practitioner Regulation Agency (AHPRA) number.

Pharmacy Assistants can enrol without an AHPRA number to access non-clinical modules.

All training will be delivered through an e-learning platform at no cost.

Access to the training is here:

Are pharmacists given a training certificate for CPD purposes?

Pharmacists that complete the mandatory COVID-19 vaccination training will receive a certificate of completion. We recommend that you keep a copy of all staff certificates as part of your usual quality assurance documentation, such as QCPP.

The information below can be used to assist you to record your completion of the COVID-19 Vaccination Training on GuildEd. If you have already self-recorded the training as a non-accredited activity, there is no need to amend this record.

The activity has been accredited for up to 5 hours of Group 1 CPD (or up to 5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to up to 5 hours of Group 2 CPD (or up to 10 CPD credits) upon successful completion of relevant assessment activities.

As not all modules are compulsory, pharmacists should review the duration of each module and record completed modules accordingly.*

  • Module 1: COVID-19: An introduction (25 minutes)
  • Module 2: Handling and storage (40 minutes)
  • Module 3: Communication and purpose (40 minutes)
  • Module 4: Multi-dose vial (MDV) training and delivery (25 minutes)
  • Module 5: Documentation and reporting (25 minutes)
  • Module 6: Safety, surveillance and reporting for adverse events following COVID-19 vaccination (30 minutes)
  • Additional module 1: Pfizer-BioNTech vaccine (30 minutes)
  • Additional module 2: AstraZeneca vaccine (30 minutes)
  • Additional module 3: Moderna vaccine (30 minutes)

This activity meets the following competency standards as set out in the 2016 National Competency Standards Framework for Pharmacists in Australia: 1.3, 2.1, 2.3, 3.1, 3.2, 3.5, 4.5

*At the rate of 1 Group 1 credit, or 2 Group 2 credits per hour of activity or part thereof. For example: Module 6 is 0.5 Group 1 credits, or 1 Group 2 credit

APC Accreditation Logo
Accreditation Code: G2021007

What will the vaccination cost our patients?

COVID-19 vaccines will be free for all Australian citizens, permanent residents and most visa-holders as per the Australian Government's COVID-19 Vaccination Policy.

How will community pharmacies be remunerated?

Community pharmacies delivering the COVID-10 vaccine will be eligible for up to $42.00 in metropolitan areas and up to $48.00 in non-metropolitan areas for each person who completes the full (two-dose) vaccination program at the same community pharmacy.

Funding for community pharmacies to administer vaccines will be provided on a fee-for-service basis via the Pharmacy Programs Administrator (PPA). The second vaccination payment** will be higher than the first vaccination payment only where a patient receives both doses of the vaccine (within the TGA approved product information for dose frequency) at the same community pharmacy.

Consistent with the Australian Government's commitment that the vaccine will be free, community pharmacies will not be permitted to charge patient co-payments for vaccine administration.

Where any part of a service is delivered through any other Federal, state or territory, or private program, the service cannot be claimed through this program.

Payment Metropolitan (MM1) Amount $
Dose 1 $16.00
Dose 2* $26.00
Total remuneration $42.00
Payment non-metropolitan (MM 2-7) Amount $
Dose 1 $19.00
Dose 2* $29.00
Total remuneration $48.00

*The second vaccination payment will be higher than the first vaccination payment only where a patient receives both doses of the vaccine (within the TGA approved product information for dose frequency) at the same community pharmacy. Otherwise, payment for a single dose administered through a community pharmacy will be in accordance with the Dose 1 rate outlined above.

Can patients receive the COVID-19 vaccine on the same day as other vaccines, such as influenza?

The Australian Technical Advisory Group on Immunisation (ATAGI) advise that routine scheduling and giving of an influenza vaccine with a COVID-19 vaccine on the same day is not recommended. The preferred minimum interval between a dose of seasonal influenza vaccine and the COVID-19 vaccine is 7 days.

There is no particular requirement regarding the order of receiving a dose of influenza vaccine and either the first or second dose of a COVID-19 vaccine.

For more information, visit: ATAGI advice on influenza and COVID-19 vaccines or Statement on the administration of seasonal influenza vaccines in 2021